Skip to main content
logo
Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China flag China · Delayed Price · Currency is CNY
8.93
-0.12 (-1.33%)
May 20, 2026, 2:25 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceutical Business
1.21B983.55M890.72M761.45M856.85M
Pharmaceutical Business Growth
22.54%10.42%16.98%-11.13%3.62%
Unallocated Other
---4.43M3.06M
Unallocated Other Growth
---44.69%690.75%
Total
1.21B983.55M890.72M765.88M859.91M
Total Growth
22.54%10.42%16.30%-10.93%3.94%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Overseas
199.87M132.16M114.90M--
Overseas Growth
51.23%15.02%---
Northeast China Region
75.64M75.05M82.31M78.89M93.80M
Northeast China Region Growth
0.79%-8.82%4.34%-15.90%31.98%
North China
190.59M164.92M184.62M168.11M201.38M
North China Growth
15.56%-10.67%9.82%-16.52%6.36%
East China
348.13M245.15M219.86M186.98M225.18M
East China Growth
42.01%11.50%17.58%-16.96%-12.04%
Southern China
114.57M129.78M93.36M57.23M36.47M
Southern China Growth
-11.72%39.01%63.12%56.92%-15.56%
Central China
136.43M125.45M103.16M109.57M137.50M
Central China Growth
8.76%21.60%-5.85%-20.31%-1.79%
Northwestern Region
27.57M19.26M17.92M17.90M24.01M
Northwestern Region Growth
43.14%7.50%0.08%-25.43%-28.24%
Southwest Region
93.68M80.75M68.17M84.58M101.93M
Southwest Region Growth
16.02%18.46%-19.40%-17.03%17.56%
Other
18.79M11.04M6.42M62.62M39.65M
Other Growth
70.13%72.04%-89.75%57.95%423.48%
Total
1.21B983.55M890.72M765.88M859.91M
Total Growth
22.54%10.42%16.30%-10.93%3.94%
Source: S&P Global Market Intelligence.